July 29, 2011 – iCAD will highlight its Xoft Axxent eBx electronic brachytherapy system at the 2011 Joint American Association of Physicists in Medicine (AAPM)/ Canadian Organization of Medical Physicists (COMP) meeting in Vancouver, British Columbia, this weekend.
At the show, iCAD will present a poster discussing dosimetry measurements for a new applicator under development for use with the Xoft system. The new interstitial applicator would enable the delivery of Xoft eBx therapy to patients who need very localized radiation delivery, such as those with spinal metastases. Authors will present at the General Poster session on Sunday, July 31 from 3:00 p.m. to 6:00 p.m. in the General Poster Area of Exhibit Hall C.
In addition, several clinicians and scientists specializing in radiation therapy and dosimetry will present information on applications for the Axxent eBx system, including its use for Intraoperative Radiation Therapy (IORT) and fundamental X-ray source calibration developments, at the “Advances in eBx” Luncheon Symposium at 12:30 p.m. on August 2, in West Wing Rooms 202-204 at the Vancouver Convention Centre.
The Axxent system uses a proprietary isotope-free miniaturized X-ray source to deliver radiation in minimally shielded environments directly to the cancerous tumor bed. The Axxent system is approved for accelerated partial breast irradiation (APBI), which can be delivered twice daily for five days, or it can be administered immediately following the lumpectomy procedure in only a few minutes with one course of therapy, also known as intraoperative radiation therapy (IORT). The system is cleared by the U.S. Food and Drug Administration (FDA) for treatment of conditions where radiation is indicated, including early stage breast cancer, skin cancer and endometrial cancer.
iCAD recently received clearance from the FDA for its new Axxent Rigid Shield, a stainless steel shielding device to protect tissue and/or organs from radiation. The Rigid Shield is intended to be used internally, such as during IORT procedures when the treatment site is surgically exposed and provides surgeons and radiation oncologists another option for shielding patients from unnecessary radiation exposure.
In addition to the Xoft system, iCAD will also showcase its magnetic resonance imaging (MRI) suite of advanced image analysis solutions, including: VividLook, SpectraLook, OmniLook, PrecisionPoint and VersaVue Enterprise, which are designed to improve accuracy for the detection of cancers and provide clinicians with objective localization, staging, treatment planning and serial monitoring.
iCAD will be at the 2011 Joint American Association of Physicists in Medicine (AAPM)/ Canadian Organization of Medical Physicists (COMP) meeting from July 31 – August 4, 2011, in booth # 1130.
For more information: www.icadmed.com
July 11, 2024 
